Abstract
Previous clinical trials in patients dying with cancer and plagued by nausea and vomiting showed that chlorpromazine hydrochloride and prochlorperazine ethane disulfonate were effective agents for the prompt control of these complications, which, previous to the advent of the phenothiazine compounds, were often uncontrollable.1Since both of these drugs did not invariably suppress vomiting and since occasional side-effects were encountered, it seemed worthwhile to evaluate the newer related compound, perphenazine, which has been recommended as an antiemetic on the basis of clinical and pharmacological studies.2 Elaborate double-blind techniques that may be required to ascertain the relative effectiveness of some therapeutic agents, such as analgesics and antiemetics in motion sickness, can be dispensed with in the study of drug effects in vomiting of terminal cancer patients. Once this symptom occurs in such patients, it is apparent that it is unaffected by most drugs and only exceptionally subject to any